|
|
|
|
| LEADER |
01890nmm a2200361 u 4500 |
| 001 |
EB000708668 |
| 003 |
EBX01000000000000000561750 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9783709175132
|
| 100 |
1 |
|
|a Kummer, Friedrich
|e [editor]
|
| 245 |
0 |
0 |
|a Treatment of Asthma: The long-acting beta-2-agonists
|h Elektronische Ressource
|c edited by Friedrich Kummer
|
| 250 |
|
|
|a 1st ed. 1998
|
| 260 |
|
|
|a Vienna
|b Springer Vienna
|c 1998, 1998
|
| 300 |
|
|
|a X, 186 p. 9 illus
|b online resource
|
| 505 |
0 |
|
|a Molecular regulation of the ?2-adrenergic receptor by long- and short-acting ?-agonists -- Molecular interactions between glucocorticoids and ?2-agonists -- Formoterol, a new long-acting ?2-agonist -- Development of the long-acting ?2-agonist, salmeterol -- Development of bambuterol; a long acting, orally active beta-agonist prodrug -- Development of ?2-receptors in infancy and childhood -- Long-acting beta-agonists in exercise induced asthma -- Salmeterol and oral steroid treatment -- Salmeterol and its relationship to treatment with inhaled corticosteroids -- Long term treatment with formoterol -- Comparison of efficiency of bambuterol and salmeterol -- The future of relievers and controllers in asthma therapy
|
| 653 |
|
|
|a Otorhinolaryngology
|
| 653 |
|
|
|a Otorhinolaryngology
|
| 653 |
|
|
|a Pharmacy
|
| 653 |
|
|
|a Pharmacy
|
| 653 |
|
|
|a Pneumology/Respiratory System
|
| 653 |
|
|
|a Allergy
|
| 653 |
|
|
|a General practice (Medicine)
|
| 653 |
|
|
|a Allergology
|
| 653 |
|
|
|a Pharmacology
|
| 653 |
|
|
|a Respiratory organs—Diseases
|
| 653 |
|
|
|a General Practice / Family Medicine
|
| 653 |
|
|
|a Pharmacology/Toxicology
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-7091-7513-2?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.2
|